FLT3-ITD is one of the most common abnormalities in AML, detected in 15 to 25% of patients, and a high ITD allelic ratio has been associated with five-year overall survival (OS) rates <35% and RR >60% [4–6]. Here, FLT3 is linked to acute myeloid leukemia.